How Can We Help?
You are here:
< Back

Morolimumab is a human monoclonal antibody against the human Rhesus factor.[1][2]

References

  1. ^ "Proposed International Nonproprietary Names: Morolimumab" (PDF). WHO Drug Information. 13 (1). Geneva: World Health Organization: 45. 1991.
  2. ^ Pelletier JP, Mukhtar F (2020). "Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies". In Maitta RW (ed.). Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. p. 300. doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. S2CID 213508934.


Categories
Table of Contents